Randomized controlled trial of vitamin d supplementation on toll-like receptor-2 (tlr-2) and toll-like receptor-4 (tlr-4) in tuberculosis spondylitis patients.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The objective of this study was to investigate the effect of oral supplementation with vitamin D on TLR-2 and TLR-4 levels in tuberculosis spondylitis patients.

Why It Was Studied

Vitamin D plays a role in the immune system.

Vitamin D helps in the activation of TLR-2 and TLR-4, which play a role in the process of tuberculosis infection.

Who Took Part

The true Experiment Design Pretest-Posttest with Control Group (Pretest-Posttest with Control Group) was used for this research.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

TLR-2 and TLR-4 were measured by ELISA.

Repeated ANOVA, ANOVA tests, and Kolmogorov-Smirnov normality tests on the SPSS program were used to statistically analyze the results.

What Was Measured

The subject headings attached to it are Toll-Like Receptor 2, Toll-Like Receptor 4, Vitamin D, Vitamin D Deficiency, Dietary Supplements and Tuberculosis, Spinal.

The authors tagged it with the keywords TLR-2, TLR-4 and Tuberculosis spondylitis.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2023 (Journal of orthopaedic surgery and research), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.